Somaxon Pharmaceuticals, Inc.(SOMX)- NASDAQ
SOMX is defunct.
  • Dec. 11, 2012, 9:10 AM

    Somaxon Pharmaceuticals (SOMX) +103.4% premarket after agreeing to be acquired by Pernix Therapeutics (PTX) in a stock-for-stock transaction valued at $25M.

    | Dec. 11, 2012, 9:10 AM
Company Description
We are a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. We submitted our NDA for Silenor®... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States